Claudia Lanvers‐Kaminsky

2.6k total citations
51 papers, 1.9k citations indexed

About

Claudia Lanvers‐Kaminsky is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Claudia Lanvers‐Kaminsky has authored 51 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 20 papers in Pediatrics, Perinatology and Child Health and 15 papers in Molecular Biology. Recurrent topics in Claudia Lanvers‐Kaminsky's work include Acute Lymphoblastic Leukemia research (21 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Adolescent and Pediatric Healthcare (8 papers). Claudia Lanvers‐Kaminsky is often cited by papers focused on Acute Lymphoblastic Leukemia research (21 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Adolescent and Pediatric Healthcare (8 papers). Claudia Lanvers‐Kaminsky collaborates with scholars based in Germany, Italy and United States. Claudia Lanvers‐Kaminsky's co-authors include Giuliano Ciarimboli, Joachim Boos, Ross Parfitt, Heribert Jürgens, Dirk Deuster, Michael Sperling, Eberhard Schlatter, Antoinette am Zehnhoff‐Dinnesen, Gudrun Würthwein and Georg Hempel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Claudia Lanvers‐Kaminsky

51 papers receiving 1.9k citations

Peers

Countries citing papers authored by Claudia Lanvers‐Kaminsky

Since Specialization

Citations

This map shows the geographic impact of Claudia Lanvers‐Kaminsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Lanvers‐Kaminsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Lanvers‐Kaminsky more than expected).

Fields of papers citing papers by Claudia Lanvers‐Kaminsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Lanvers‐Kaminsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Lanvers‐Kaminsky. The network helps show where Claudia Lanvers‐Kaminsky may publish in the future.

Co-authorship network of co-authors of Claudia Lanvers‐Kaminsky

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Lanvers‐Kaminsky. A scholar is included among the top collaborators of Claudia Lanvers‐Kaminsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Lanvers‐Kaminsky. Claudia Lanvers‐Kaminsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcome 2024 ·Blood ·(unknown), (unknown), (unknown), (unknown), Stephanie Müller, (unknown), Claudia Sopalla, Claudia Lanvers‐Kaminsky, Marc Hotfilder, (unknown), Christine Damm‐Welk, (unknown), Gabriele Escherich, Udo zur Stadt, (unknown), Wilhelm Woessmann, Ilske Oschlies, (unknown), Martin Zimmermann, Birgit Burkhardt	1
2	Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data 2021 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Gudrun Würthwein, Claudia Lanvers‐Kaminsky, (unknown), Joachim Gerß, Anja Möricke, Martin Zimmermann, Jan Starý, Petr Smíšek, Martin Schrappe, Carmelo Rizzari, Massimo Zucchetti, Georg Hempel, Sebastian G. Wicha, Joachim Boos	9
3	A comparison of genotyping arrays 2021 ·European Journal of Human Genetics ·Joost Verlouw, Eva Clemens, (unknown), Oliver Zolk, Annemieke J.M.H. Verkerk, Antoinette am Zehnhoff‐Dinnesen, Carolina Medina‐Gómez, Claudia Lanvers‐Kaminsky, Fernando Rivadeneira, Thorsten Langer, Joyce B. J. van Meurs, Marry M. van den Heuvel‐Eibrink, André G. Uitterlinden, Linda Broer	51
4	Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach 2021 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Claudia Lanvers‐Kaminsky, Julia Alten, Petr Smíšek, Christa E. Nath, Carmelo Rizzari, Joachim Boos, Gudrun Würthwein	4
5	Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring 2020 ·Scientific Reports ·(unknown), Claudia Lanvers‐Kaminsky, Gudrun Würthwein, Georg Hempel, Joachim Boos	14
6	Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated <i>E. coli</i> asparaginase in children with acute lymphocytic leukemia 2020 ·Haematologica ·(unknown), Gudrun Würthwein, (unknown), Georg Hempel, Manfred Fobker, Joachim Gerß, Anja Möricke, Martin Zimmermann, Petr Smíšek, Massimo Zucchetti, Christa E. Nath, Andishe Attarbaschi, Arend von Stackelberg, Nicola Gökbuget, Carmelo Rizzari, Valentino Conter, Martin Schrappe, Joachim Boos, Claudia Lanvers‐Kaminsky	33
7	Preclinical Evaluation of Combined Topoisomerase and Proteasome Inhibition Against Pediatric Malignancies 2018 ·Anticancer Research ·(unknown), Joachim Boos, Claudia Lanvers‐Kaminsky	5
8	Asparaginase pharmacology: challenges still to be faced 2017 ·Cancer Chemotherapy and Pharmacology ·Claudia Lanvers‐Kaminsky	43
9	Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors 2016 ·Cancer Chemotherapy and Pharmacology ·(unknown), Joachim Boos, Claudia Lanvers‐Kaminsky	11
10	Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models 2015 ·PLoS ONE ·Estelle Daudigeos‐Dubus, Ludivine Le Dret, Claudia Lanvers‐Kaminsky, Olivia Bawa, Paule Opolon, (unknown), Irène Villa, Mélanie Pagès, Jacques Bosq, Gilles Vassal, Dieter Zopf, Birgit Geoerger	37
11	A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia 2014 ·Blood ·Wing H. Tong, Rob Pieters, Gertjan J.L. Kaspers, D. Maroeska W. M. te Loo, Marc Bierings, Cor van den Bos, Wouter J.W. Kollen, Wim C.J. Hop, Claudia Lanvers‐Kaminsky, Mary V. Relling, Wim J. E. Tissing, Inge M. van der Sluis	155
12	No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy 2012 ·Pediatric Blood & Cancer ·Wing H. Tong, Rob Pieters, Wim C.J. Hop, Claudia Lanvers‐Kaminsky, Joachim Boos, Inge M. van der Sluis	14
13	Five‐year single‐center study of asparaginase therapy within the ALL‐BFM 2000 trial 2011 ·Pediatric Blood & Cancer ·(unknown), (unknown), Claudia Lanvers‐Kaminsky, Joachim Gerß, Anja Möricke, Joachim Boos	8
14	Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions 2010 ·American Journal Of Pathology ·Giuliano Ciarimboli, Dirk Deuster, Arne Knief, Michael Sperling, Michael Holtkamp, Bayram Edemir, Hermann Pavenstädt, Claudia Lanvers‐Kaminsky, Antoinette am Zehnhoff‐Dinnesen, Alfred H. Schinkel, Hermann Koepsell, Heribert Jürgens, Eberhard Schlatter	340
15	Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines 2010 ·Anti-Cancer Drugs ·(unknown), Claudia Lanvers‐Kaminsky, (unknown), Michael C. Frühwald	20
16	A population pharmacokinetic model for pegylated‐asparaginase in children 2009 ·British Journal of Haematology ·Georg Hempel, Hans‐Joachim Müller, Claudia Lanvers‐Kaminsky, Gudrun Würthwein, (unknown), Joachim Boos	30
17	In-vitro toxicity of Ukrain against human Ewing tumor cell lines 2006 ·Anti-Cancer Drugs ·Claudia Lanvers‐Kaminsky, (unknown), Julia Köster, (unknown), (unknown), Joachim Boos	14
18	Serum asparaginase activities and asparagine concentrations in the cerebrospinal fluid after a single infusion of 2,500 IU/m2 PEG asparaginase in children with ALL treated according to protocol COALL-06-97 2005 ·Pediatric Blood & Cancer ·João Paulo Vieira Pinheiro, (unknown), Gabriele Escherich, Claudia Lanvers‐Kaminsky, Gudrun Würthwein, G. Janka‐Schaub, Joachim Boos	34
19	Continuous or repeated prolonged cisplatin infusions in children: A prospective study on ototoxicity, platinum concentrations, and standard serum parameters 2005 ·Pediatric Blood & Cancer ·Claudia Lanvers‐Kaminsky, (unknown), (unknown), Dirk Deuster, Eberhard Seifert, Gudrun Würthwein, Ulrich Jaehde, (unknown), Joachim Boos	45
20	In vitro toxicity of bisphosphonates on human neuroblastoma cell lines 2004 ·Anti-Cancer Drugs ·(unknown), Joachim Boos, Claudia Lanvers‐Kaminsky	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact